These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 1972772

  • 21. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC.
    Cancer Res; 1993 Nov 01; 53(21):5225-32. PubMed ID: 8106143
    [Abstract] [Full Text] [Related]

  • 22. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    Politi PM, Sinha BK.
    Mol Pharmacol; 1989 Mar 01; 35(3):271-8. PubMed ID: 2564628
    [Abstract] [Full Text] [Related]

  • 23. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity.
    Schecter RL, Alaoui-Jamali MA, Woo A, Fahl WE, Batist G.
    Cancer Res; 1993 Oct 15; 53(20):4900-6. PubMed ID: 8402679
    [Abstract] [Full Text] [Related]

  • 24. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F, Jongsma AP, Broxterman HJ, Arceci RJ, Housman D, Scheffer GL, Riethorst A, van Groenigen M, Nieuwint AW, Joenje H.
    Cancer Res; 1990 Sep 01; 50(17):5392-8. PubMed ID: 1974823
    [Abstract] [Full Text] [Related]

  • 25. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
    Ford JM, Bruggemann EP, Pastan I, Gottesman MM, Hait WN.
    Cancer Res; 1990 Mar 15; 50(6):1748-56. PubMed ID: 1968358
    [Abstract] [Full Text] [Related]

  • 26. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
    Wang X, Kong L, Zhao J, Yang P.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul 15; 24(4):339-43. PubMed ID: 12408759
    [Abstract] [Full Text] [Related]

  • 27. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B, Ye T, Zhao L, Li DH, Gou XH, Zhao LY, Han L, Chen L, Yan LN, Gong JP.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 15; 5(4):552-9. PubMed ID: 17085341
    [Abstract] [Full Text] [Related]

  • 28. Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.
    Ahmad S, Glazer RI.
    Mol Pharmacol; 1993 Jun 15; 43(6):858-62. PubMed ID: 8100351
    [Abstract] [Full Text] [Related]

  • 29. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.
    Ban N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S, Niitsu Y.
    Cancer Res; 1996 Aug 01; 56(15):3577-82. PubMed ID: 8758929
    [Abstract] [Full Text] [Related]

  • 30. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Aug 01; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 31. Genes amplified and overexpressed in human multidrug-resistant cell lines.
    Van der Bliek AM, Baas F, Van der Velde-Koerts T, Biedler JL, Meyers MB, Ozols RF, Hamilton TC, Joenje H, Borst P.
    Cancer Res; 1988 Nov 01; 48(21):5927-32. PubMed ID: 2901906
    [Abstract] [Full Text] [Related]

  • 32. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y, Wu WJ, Kim WJ, Arao S, Fukumoto M, Yoshida O.
    Int J Urol; 1995 Nov 01; 2(5):309-15. PubMed ID: 8749949
    [Abstract] [Full Text] [Related]

  • 33. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B, Safa AR.
    Biochemistry; 1999 Feb 16; 38(7):2189-99. PubMed ID: 10026303
    [Abstract] [Full Text] [Related]

  • 34. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
    Aftab DT, Yang JM, Hait WN.
    Oncol Res; 1994 Feb 16; 6(2):59-70. PubMed ID: 7949466
    [Abstract] [Full Text] [Related]

  • 35. Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms.
    Slovak ML, Coccia M, Meltzer PS, Trent JM.
    Anticancer Res; 1991 Feb 16; 11(1):423-8. PubMed ID: 1673331
    [Abstract] [Full Text] [Related]

  • 36. [Role of glutathione S-transferase pi in tumor drug resistance].
    Cao W, Zuo J, Fang F.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct 16; 21(5):402-6. PubMed ID: 12567441
    [Abstract] [Full Text] [Related]

  • 37. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
    Ahmad S, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Glazer RI.
    Mol Pharmacol; 1992 Dec 16; 42(6):1004-9. PubMed ID: 1362242
    [Abstract] [Full Text] [Related]

  • 38. Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin.
    Kim R, Hirabayashi N, Nishiyama M, Jinushi K, Toge T, Okada K.
    Anticancer Res; 1992 Dec 16; 12(1):241-5. PubMed ID: 1314532
    [Abstract] [Full Text] [Related]

  • 39. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
    Nieuwint AW, Baas F, Wiegant J, Joenje H.
    Cancer Res; 1992 Aug 15; 52(16):4361-71. PubMed ID: 1353703
    [Abstract] [Full Text] [Related]

  • 40. Expression of tandem glutathione S-transferase recombinant genes in COS cells for analysis of efficiency of protein expression and associated drug resistance.
    Manoharan TH, Welch PJ, Gulick AM, Puchalski RB, Lathrop AL, Fahl WE.
    Mol Pharmacol; 1991 Apr 15; 39(4):461-7. PubMed ID: 1850090
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.